aDepartment of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science

bDepartment of Endocrinology and Metabolism, Kyoto First Red Cross Hospital

cDepartment of Endocrinology and Metabolism, Kyoto Second Red Cross Hospital, Kyoto

dDepartment of Endocrinology and Metabolism, Osaka General Hospital of West Japan Railway Company, Osaka

eDepartment of Cardiology, Nishijin Hospital

fDepartment of Biostatistics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science

gDepartment of Organ Transplantation and General Surgery, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan

Correspondence to Emi Ushigome, MD, PhD, Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan. Tel: +81 75 251 5505; fax: +81 75 252 3721; e-mail: [email protected]

Abbreviations: BP, blood pressure; CCB, calcium channel blockers; DBP, diastolic blood pressure; EASD, European Association for the Study of Diabetes; ESC, European Society of Cardiology; HBP, home blood pressure; HR, hazard ratio; IQR, interquartile range; OHA, oral hypoglycemic agent; ROC, receiver operating characteristic; SBP, systolic blood pressure; SHATS, systemic hemodynamic atherothrombotic syndrome

Received 6 February, 2022

Revised 8 July, 2022

Accepted 17 July, 2022

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.jhypertension.com).